Literature DB >> 7857732

Association between reduced heart rate variability and left ventricular dilatation in patients with a first anterior myocardial infarction. CATS Investigators. Captopril and Thrombolysis Study.

J H Dambrink1, Y S Tuininga, W H van Gilst, K H Peels, K I Lie, J H Kingma.   

Abstract

BACKGROUND: Reduced heart rate variability has been identified as an important prognostic factor after myocardial infarction. This factor is thought to reflect an imbalance between sympathetic and parasympathetic activity, which may lead to unfavourable loading conditions and thus promote left ventricular dilatation. PATIENTS AND METHODS: 298 patients in a multicentre clinical trial were randomised to captopril or placebo after a first anterior myocardial infarction. All patients were treated with streptokinase before randomisation. In the present substudy full data including heart rate variability and echocardiographic measurements were available from 80 patients. Patients were divided into two groups: those with a reduced (< or = 25) heart rate variability index and those with normal heart rate variability index (> 25). Heart rate variability was evaluated by 24 h Holter monitoring before discharge. Left ventricular volumes were assessed by echocardiography before discharge and three and 12 months after myocardial infarction. Extent of myocardial injury, severity of coronary artery disease, functional class, haemodynamic variables, and medication were also considered as possible determinants of left ventricular dilatation.
RESULTS: Before discharge end systolic and end diastolic volumes were not different in the two groups. After 12 months in patients with a reduced heart rate variability, end systolic volume (mean (SD)) had increased by 6 (14) ml/m2 (P = 0.043) and end diastolic volume had increased by 8 (17) ml/m2 (P = 0.024). Left ventricular volumes were unchanged in patients with a normal heart rate variability. Also, patients with left ventricular dilatation had a larger enzymatic infarct size and higher heart rates and rate-pressure products. A reduced heart rate variability index before discharge was an independent risk factor for left ventricular dilatation during follow up. Measurement of heart rate variability after three months had no predictive value for this event.
CONCLUSION: Assessment of the heart rate variability index before discharge, but not at three months, gave important additional information for identifying patients at risk of left ventricular dilatation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7857732      PMCID: PMC1025635          DOI: 10.1136/hrt.72.6.514

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  30 in total

1.  Circadian variation and influence of risk factors on heart rate variability in healthy subjects.

Authors:  H Mølgaard; K E Sørensen; P Bjerregaard
Journal:  Am J Cardiol       Date:  1991-09-15       Impact factor: 2.778

2.  Heart rate variability during the acute phase of myocardial infarction.

Authors:  G C Casolo; P Stroder; C Signorini; F Calzolari; M Zucchini; E Balli; A Sulla; S Lazzerini
Journal:  Circulation       Date:  1992-06       Impact factor: 29.690

3.  Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition.

Authors:  N Sharpe; H Smith; J Murphy; S Greaves; H Hart; G Gamble
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

4.  Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R C Steinman; L M Rolnitzky; R E Kleiger; J N Rottman
Journal:  Am J Cardiol       Date:  1992-04-01       Impact factor: 2.778

5.  Stability over time of heart period variability in patients with previous myocardial infarction and ventricular arrhythmias. The CAPS and ESVEM investigators.

Authors:  J T Bigger; J L Fleiss; L M Rolnitzky; R C Steinman
Journal:  Am J Cardiol       Date:  1992-03-15       Impact factor: 2.778

6.  Clinical, hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure.

Authors:  M G Kienzle; D W Ferguson; C L Birkett; G A Myers; W J Berg; D J Mariano
Journal:  Am J Cardiol       Date:  1992-03-15       Impact factor: 2.778

7.  Effect of vagal nerve electrostimulation on the power spectrum of heart rate variability in man.

Authors:  M V Kamath; A R Upton; A Talalla; E L Fallen
Journal:  Pacing Clin Electrophysiol       Date:  1992-02       Impact factor: 1.976

8.  Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure.

Authors:  P F Binkley; E Nunziata; G J Haas; S D Nelson; R J Cody
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

9.  Reproducibility and relation to mean heart rate of heart rate variability in normal subjects and in patients with congestive heart failure secondary to coronary artery disease.

Authors:  D Van Hoogenhuyze; N Weinstein; G J Martin; J S Weiss; J W Schaad; X N Sahyouni; D Fintel; W J Remme; D H Singer
Journal:  Am J Cardiol       Date:  1991-12-15       Impact factor: 2.778

Review 10.  Cellular basis of ventricular remodeling after myocardial infarction.

Authors:  P Anversa; G Olivetti; J M Capasso
Journal:  Am J Cardiol       Date:  1991-11-18       Impact factor: 2.778

View more
  6 in total

1.  Measurement and interpretation of blood pressure.

Authors:  C D Goonasekera; M J Dillon
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

2.  Prognostic value of left ventricular diastolic function and association with heart rate variability after a first acute myocardial infarction.

Authors:  S H Poulsen; S E Jensen; J E Møller; K Egstrup
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

3.  ACE inhibitors after myocardial infarction: patient selection or treatment for all?

Authors:  O M Jolobe
Journal:  Br Heart J       Date:  1995-11

Review 4.  Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment.

Authors:  Y S Tuininga; D J van Veldhuisen; J Brouwer; J Haaksma; H J Crijns; A J Man in't Veld; K I Lie
Journal:  Br Heart J       Date:  1994-12

5.  Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.

Authors:  F Cecchi; I Olivotto; A Montereggi; G Squillatini; A Dolara; B J Maron
Journal:  Heart       Date:  1998-04       Impact factor: 5.994

6.  Ambulatory electrocardiography, heart rate variability, and pharmacologic stress testing in cats with subclinical hypertrophic cardiomyopathy.

Authors:  Ashley L Walker; Yu Ueda; Amanda E Crofton; Samantha P Harris; Joshua A Stern
Journal:  Sci Rep       Date:  2022-02-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.